Safety of acupuncture: results of a prospective observational study with 229,230 patients and introduction of a medical information and consent form by Witt, Claudia M et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2009
Safety of acupuncture: results of a prospective observational study with
229,230 patients and introduction of a medical information and consent form
Witt, Claudia M; Pach, Daniel; Brinkhaus, Benno; Wruck, Katja; Tag, Brigitte; Mank, Sigrid; Willich,
Stefan N
Abstract: Unbekannt
DOI: 10.1159/000209315
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-31481
Veröffentlichte Version
Originally published at:
Witt, Claudia M; Pach, Daniel; Brinkhaus, Benno; Wruck, Katja; Tag, Brigitte; Mank, Sigrid; Willich,
Stefan N (2009). Safety of acupuncture: results of a prospective observational study with 229,230 patients
and introduction of a medical information and consent form. Forschende Komplementärmedizin, 16(2):91-
97. DOI: 10.1159/000209315
Original Article· Originalarbeit
Forsch Komplementmed 2009;16:91–97 Publishedonline: April 9, 2009
DOI: 10.1159/000209315
Prof. Dr. Claudia Witt 
Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie 
Charité Universtitätsmedizin, 10098 Berlin, Germany
Tel. +49 30 450529002, Fax 450529902 
claudia.witt@charite.de
© 2009 S. Karger GmbH, Freiburg
Accessible online at: 
www.karger.com/fok
Fax +49 761 4 52 07 14
Information@Karger.de
www.karger.com
Safety of Acupuncture: Results of a Prospective  
Observational Study with 229,230 Patients and  
Introduction of a Medical Information and Consent Form 
Claudia M. Witta  Daniel Pacha  Benno Brinkhausa  Katja Wrucka  Brigitte Tagb   
Sigrid Manka  Stefan N. Willicha 
a Institute for Social Medicine, Epidemiology, and Health Economics, Charité University Medical Center, Berlin, Germany 
b Chair of Criminal Law, Criminal Proceeding and Medical Law, University of Zurich, Switzerland
Key Words 
Acupuncture · Safety · Adverse effects · Adverse events · Informed 
consent · Information and consent forms
Summary
Background: To evaluate the safety of acupuncture in a large 
number of patients receiving conventional health care and, based 
on these results, to develop a new medical consent form for acu-
puncture. Methods: The prospective observational study included 
patients who received acupuncture treatment for chronic osteoar-
thritis pain of the knee or hip, low back pain, neck pain or head-
ache, allergic rhinitis, asthma, or dysmenorrhoea. After treatment, 
all patients documented adverse events associated with acupunc-
ture (defined as adverse effects). Patients who reported a need for 
treatment due to an adverse effect completed an additional stand-
ardised questionnaire on the most important adverse effect. Based 
on this data and considering ethical and legal aspects a new con-
sent form was developed. Results: A total of 229,230 patients re-
ceived on average 10.2 ± 3.0 acupuncture treatments. Altogether, 
19,726 patients (8.6%) reported experiencing at least one adverse 
effect and 4,963 (2.2%) reported one which required treatment. 
Common adverse effects were bleedings or haematoma (6.1% of 
patients, 58% of all adverse effects), pain (1.7%) and vegetative 
symptoms (0.7%). Two patients experienced a pneumothorax (one 
needed hospital treatment, the other observation only). The longest 
duration of a side effect was 180 days (nerve lesion of the lower 
limb). The resulting medical consent form consists of five modules: 
Introduction to acupuncture and moxibustion, Risks of acupuncture 
treatment, Conditions which can increase the risk, Doctor’s state-
ment, and Consent. Conclusion: Acupuncture provided by physi-
cians is a relatively safe treatment and the proposed consent form 
could support both patients and professionals in the process of ob-
taining informed consent.
Schlüsselwörter 
Akupunktur · Sicherheit · Nebenwirkungen · Unerwünschte  
Ereignisse · Informierte Einwilligung · Aufklärungsbogen
Zusammenfassung
Hintergrund: Ziel der Studie war es, die Sicherheit von Akupunktur 
in einem großen Patientenkollektiv in der Normalversorgung zu un-
tersuchen und auf Basis der resultierenden Daten einen Akupunk-
turaufklärungsbogen für die Normalversorgung zu entwickeln. Me-
thoden: In eine prospektive Beobachtungsstudie wurden Patienten 
aufgenommen, die Akupunktur wegen folgender Diagnosen erhiel-
ten: chronische Schmerzen aufgrund von Osteoarthrose des Knies 
oder der Hüfte, Schmerzen der Lendenwirbelsäule, Kopfschmerzen 
und Schmerzen der Halswirbelsäule, allergische Rhinitis, Asthma 
und Dysmenorrhoe. Am Ende der Akupunkturbehandlung wurden 
alle Patienten nach Nebenwirkungen befragt, die sie mit der Aku-
punktur in Zusammenhang brachten. Patienten, die die Behand-
lungsbedürftigkeit einer Nebenwirkung berichteten, erhielten einen 
zusätzlichen Fragebogen zur bedeutendsten Nebenwirkung. Auf 
Grundlage dieser Daten und unter Beachtung von ethischen und 
juristischen Aspekten wurde ein Patientenaufklärungsbogen entwi-
ckelt. Ergebnisse: Insgesamt wurden 229 230 Patienten in die Studie 
eingeschlossen. Die Patienten erhielten im Durchschnitt 10,2 ± 3,0 
Behandlungen. 19 726 Patienten (8,6%) berichteten von mindestens 
einer Nebenwirkung und 4963 (2,2%) benötigten deswegen eine Be-
handlung. 24 377 Nebenwirkungen wurden berichtet. Häufige Ne-
benwirkungen sind Blutungen oder Hämatome (6,1% der Patienten, 
58% aller Nebenwirkungen) sowie Schmerz (1,7%), gefolgt von ve-
getativen Symptomen (0,7%). Bei 2 Patienten wurde ein Pneumo-
thorax durch die Akupunktur verursacht. Ein Patient benötigte des-
wegen eine Krankenhausbehandlung, bei dem anderen genügte die 
weitere Beobachtung. Die mit 180 Tagen am längsten andauernde 
Nebenwirkung war eine Nervenläsion am Unterschenkel. Der resul-
tierende Aufklärungsbogen umfasst fünf Module: Einführung in die 
Akupunktur und Moxibustion, Risiken der Akupunkturbehandlung, 
Bedingungen, die das Risiko erhöhen können, Ärztliche Anmer-
kungen und Einwilligung. Schlussfolgerung: Die von Ärzten durch-
geführte Akupunktur ist eine relativ sichere Behandlungsform. Der 
vorgeschlagene Aufklärungsbogen könnte Patienten und Ärzte bei 
der Aufklärung vor der Einwilligung unterstützen.
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Introduction
Today, acupuncture is often used [1–3] and increasingly inte-
grated into conventional care. It is administered on the basis 
of positive evidence for pain-related conditions such as oste-
oarthritis of the knee [4–6] as well as postoperative and chemo-
therapy-induced nausea and vomiting [7, 8]. Despite the lack 
of positive scientific evidence, it is also used for other condi-
tions such as asthma [9] and smoking cessation [10]. But side 
effects, even severe ones like pneumothorax, cardiac tampon-
ade, and infections can occur [11–22] and a patient should be 
informed about these. Some authors, however, point out that 
many of these events may have been caused by malpractice or 
negligence [19, 23, 24] suggesting that they could be avoided.
An important part of health care (including acupuncture) 
consists of providing patient information and gaining informed 
consent. However, this is time consuming and therefore often 
neglected. Additionally, sometimes the scientific basis for this 
information is incomplete. 
Informed consent is the legal basis for medical treatments. 
In Germany, any medical intervention is considered to con-
tain the elements of the legal offence known as physical in-
jury, as defined by §§ 223 et seqq. StGB (Strafgesetzbuch, 
Criminal Code); 823 BGB (Bürgerliches Gesetzbuch, German 
Civil Code). This position, espoused by the Imperial Court of 
Justice (Reichsgericht) in 1894 (RGSt 25, 375), has been con-
sistently maintained by the German Federal Court of Justice 
(Bundesgerichtshof) (BGHSt 35, 246) [25]. Yet, in order to 
gain adequate informed consent before acupuncture treat-
ments, detailed patient information and a discussion about 
possible treatment risks associated with acupuncture is impor-
tant. However, for this purpose valid data on the side effects of 
acupuncture and their frequency of occurrence is necessary.
Until recently, most data available was based on anecdotal 
reports [16] or on practitioners’ self reports [18, 26–29]. The 
aim of the Acupuncture Safety and Health Economics Study 
(ASH) was to investigate safety in German usual care includ-
ing self-reports of a large number of patients. The ASH was 
part of a large research initiative supported by the health sick-
ness funds. The additional aim of this article is to provide a 
consent form for acupuncture which uses these new data to 
inform patients about possible side effects. 
Methods
Observational Study
The prospective observational study included all out-patients (age ≥ 18 
years) from participating health sickness funds who received acupunc-
ture treatment for chronic osteoarthritis pain of the knee or hip, low 
back pain, neck pain or headache, allergic rhinitis, asthma, or dysmenor-
rhoea between December 2000 and August 2004 [30, 31]. Acupuncture 
was provided by physicians with postgraduate acupuncture training of at 
least 140 h. At the end of each treatment cycle, all patients were asked to 
complete a standardised questionnaire and to document adverse events 
they associated with acupuncture (defined as adverse effects) in free text 
and, if necessary, the kind of treatment they had needed (self-treatment, 
medication/physician treatment, treatment in hospital). Adverse events 
without association to the acupuncture treatment were not documented. 
Patients who reported adverse effects which needed treatment, received 
from the study office an additional, more detailed standardised question-
naire concerning their most important adverse effect. 
For analysis, adverse effects were categorised by specially trained staff 
using categories which were developed in a consensus process between 
MDs, acupuncturists, epidemiologists and psychologists.
Development of the Consent Form
The frequency of adverse effects was classified according to the guide-
lines of the European Commission used to describe adverse effects of 
medicinal products (very common (≥1/10); common (≥1/100 to <1/10); 
uncommon (≥1/1,000 to ≤1/100); rare (≥1/10,000 to ≤1/1,000); very rare 
(≤1/10,000), not known) [32].
On the basis of the study results, existing material (www.uni-essen/
naturheilkunde), and considering ethical and legal aspects of informed 
consent [20, 25, 33, 34], a consent form on medical acupuncture was devel-
oped. Besides information about the patient’s ailment, the nature of the 
proposed treatment, the benefits of the treatment, and reasonable treat-
ment alternatives we focused on detailed information about risks similar 
to the European medicinal product information [32] used in European 
patient information leaflets.
The ASH study was approved by the appropriate ethics committees 
and all patients provided written informed consent. SPSS 11.5 (SPSS Inc., 
Chicago, IL, USA) was used for data analysis.
Results
Observational Study
A total of 13,579 physicians (mean age 46.0 ± 7.4, 61.1% male) 
practising acupuncture in Germany participated in the present 
study. All physicians had at least 140 h of acupuncture train-
ing (German A diploma) and on average 6.9 ± 5.3 years of 
acupuncture practice, 15.4% had ≥350 h of training (German 
B diploma). Half of the physicians (48.3%) were general prac-
titioners, 18.8% orthopaedists, 10.4% internists, 4.5% anaes-
thetists, 4.4% gynaecologists, and 13.6% had other specialisa-
tions. On average, they treated 11.7 ± 15.7% of their patients 
with acupuncture.
229,230 patients (mean age 51.0 ± 14.3 years (95% CI 51.0–
51.1), 64.8% female) were enrolled and received on average 
10.17 ± 3.0 (10.16–10.18) acupuncture treatments. The anal-
ysis is thus based on 2.2 million acupuncture sessions. Alto-
gether, 19,726 patients (8.6%) reported experiencing at least 
1 adverse effect. Adverse effects requiring treatment occurred 
in 2.2% of patients (n = 4,963). Overall, 24,377 adverse effects 
were reported. Common adverse effects were minor bleeding 
or haematoma (6.1%) and pain (1.7%) followed by vegeta-
tive symptoms (0.7%) (table 1). Bleeding or haematoma was 
the predominant adverse effect (58% of all adverse effects, 
fig. 1). Adverse effects which indicate negligence or malprac-
tice (broken or forgotten needle, pneumothorax, burns after 
moxibustion) occurred in 0.1% of all adverse effects.
Of the adverse effects 39.4% occurred during and 60.6% 
after the treatment sessions. Two cases of pneumothorax oc-
curred, both immediately after and caused by acupuncture; 
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Fig. 1. ASH study: Most frequent adverse  
effects of acupuncture in condensed categories.
Table 1. Acupuncture adverse effects; total study population: n = 229,230
Frequency No need for treatment Need for treatment Frequency in text forma
N % n % n %
Bleeding/haematoma 14083 6.144 11468 5.00 2615 1.14 common
Inflammation   711 0.310  382 0.17  329 0.14 uncommon
Inflammation at application site   680 0.297  375 0.16  305 0.13 uncommon
Local infection    31 0.014   7 0.003  24 0.01 rare
Pain  4681 2.042  2209 0.96 2472 1.08 common
Headache  1200 0.523  462 0.20  738 0.32 uncommon
Aggravation of symptoms, symptomatology   712 0.311  384 0.17  328 0.14 uncommon
Local muscle pain   548 0.239  261 0.11  287 0.13 uncommon
Strong pain during needling   490 0.214  283 0.12  207 0.09 uncommon
Generalised muscle pain    73 0.032   23 0.01  50 0.02 rare
Other pain  1658 0.723  796 0.35  862 0.38 uncommon
Vegetative symptoms  1663 0.725  873 0.38  790 0.34 uncommon
Vertigo   514 0.224  256 0.11  258 0.11 uncommon
Nausea   332 0.145  177 0.08  155 0.07 uncommon
Sweating    96 0.042   56 0.02  40 0.02 rare
Depression of blood pressure    86 0.038   42 0.02  44 0.02 rare
Unconsciousness    62 0.027   35 0.02  27 0.01 rare
Tachycardia    47 0.021   24 0.01  23 0.01 rare
Breathing difficulties    35 0.015   22 0.01  13 0.01 rare
Increase in blood pressure    30 0.013   11 0.005  19 0.01 rare
Constipation     8 0.003   0 0.00   8 0.003 very rare
Palpitations     6 0.003   6 0.003   0 0.00 very rare
Enterospasm     4 0.002   4 0.002   0 0.00 very rare
Weight reduction     2 0.001   2 0.0009   0 0.00 very rare
Circulatory disturbance     1 0.0004   1 0.0004   0 0.00 very rare
Other cardiac or circulatory disturbance   440 0.192  237 0.10  203 0.09 uncommon
Nerve irritation/injuries   601 0.262  350 0.15  251 0.11 uncommon
Paraesthesia   221 0.096  125 0.05  96 0.04 rare
Hypaesthesia  181 0.079  124 0.05  57 0.02 rare
Nerve irritation  130 0.057   74 0.03  56 0.02 rare
Paresis   38 0.017   14 0.01  24 0.01 rare
Nerve injury   31 0.014   13 0.01  18 0.01 rare
Others  2638 1.151  1302 0.57 1336 0.58 common
Fatigue  491 0.214  315 0.14  176 0.08 uncommon
Swelling  346 0.151  145 0.06  201 0.09 uncommon
Worsening health state  209 0.091  112 0.05  97 0.04 rare
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one patient required hospital treatment, the other was less 
seriously affected and required observation, only. The longest 
duration of a side effect was 180 days (nerve lesion of the lower 
limb). There were no acupuncture-associated deaths or perma-
nent injuries associated with the acupuncture treatments. 
Development of the Consent Form
The medical acupuncture consent form that has been devel-
oped consists of five modules: Introduction into acupuncture 
and moxibustion, Risks of acupuncture treatment, Conditions 
which can increase the risk, Doctor’s statement, and Consent. 
We decided to provide modules in order to allow that parts 
can be included in existing consent forms. Risks are shown in 
English (fig. 2), since they are relatively independent of coun-
try-specific influences. There is a free download of the full 
German version at www.karger.com/doi/10.1159/000209315 
and www.charite.de/cam). The authors regret that they can-
not assume liability for errors or omissions. Ideally, patients 
should be informed 24 h prior to the first acupuncture session.
Discussion
The data from the observational study presented here show 
a variety of adverse effects accompanying acupuncture pro-
vided by German physicians. These adverse effects were not 
rare and occurred in 8.6% of the sampled patients. However, 
most of them were only minor events, like bleedings or hae-
matoma, pain or vegetative symptoms. However, very severe 
side effects such as pneumothorax or nerve lesions do occur 
and patients should be made aware of them. The medical con-
sent form for acupuncture made up of five modules, includ-
ing information on possible side effects, is the first to provide 
information for the patient similar to instruction leaflets en-
closed in any European box of medication.
The analysis is based on a large sample of 229,230 patients 
with more than 2 million acupuncture sessions in usual care 
setting. Moreover, in this study all patients from participat-
ing health sickness funds who received acupuncture treatment 
reported adverse effects directly. This study setting allows to 
Other dermal phenomena  205 0.089   92 0.04  113 0.05 rare
Itching  174 0.076   98 0.04  76 0.03 rare
Other neurological complaints  159 0.069   66 0.03  93 0.04 rare
Redness  147 0.064  102 0.04  45 0.02 rare
Restricted movement  117 0.051   52 0.02  65 0.03 rare
Sleep disturbance   97 0.042   40 0.02  57 0.02 rare
Joint problems   71 0.031   35 0.02  36 0.02 rare
Other mood swings   71 0.031   25 0.01  46 0.02 rare
Anxiety   55 0.024   22 0.01  33 0.01 rare
Vomiting   49 0.021   11 0.005  38 0.02 rare
Restlessness/nervousness   45 0.020   28 0.01  17 0.01 rare
Disturbed vision   45 0.020   19 0.01  26 0.01 rare
Other gastrointestinal complaints   45 0.020   15 0.01  30 0.01 rare
Feeling of coldness   36 0.016   14 0.01  22 0.01 rare
Depressive mood   35 0.015   9 0.004  26 0.01 rare
Menstrual problems   32 0.014   17 0.01  15 0.01 rare
Tinnitus   23 0.010   7 0.003  16 0.01 rare
Gastrospasm   19 0.008   8 0.003  11 0.005 very rare
Diarrhoea   16 0.007   4 0.002  12 0.01 very rare
Imbalance   15 0.007   6 0.003   9 0.004 very rare
Burns after moxibustion   14 0.006   4 0.002  10 0.004 very rare
Shivering   13 0.006   9 0.004   4 0.002 very rare
Needle forgotten   12 0.005   8 0.003   4 0.002 very rare
Poor concentration   9 0.004   3 0.001   6 0.003 very rare
Eye irritation   6 0.003   2 0.001   4 0.002 very rare
Lesion of blood vessels   5 0.002   3 0.001   2 0.001 very rare
Systemic infection   5 0.002   2 0.001   3 0.001 very rare
Nightmares   4 0.002   2 0.001   2 0.001 very rare
Euphoria   3 0.001   1 0.0004   2 0.001 very rare
Disturbance of speech   3 0.001   1 0.0004   2 0.001 very rare
Needle broken   2 0.001   0 0.00   2 0.001 very rare
Pneumothorax   2 0.001   0 0.00   2 0.001 very rare
Disorientation   2 0.001   2 0.001   0 0.00 very rare
Other adverse events   56 0.024   23 0.01  33 0.01 rare
aAccording to the guidelines of the European Commission used to describe adverse effects of medicinal products (very common (≥1/10);  
common (≥1/100 to <1/10); uncommon (≥1/1,000 to ≤1/100); rare (≥1/10,000 to ≤1/1,000); very rare (≤1/10,000), not known) [32].
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Risks of acupuncture treatment
Like all treatments, acupuncture can cause side effects. The following ranking is used:
Very common: more than 1 out of 10 treated people 
Common: 1 to 10 out of 100 treated people 
Uncommon: 1 to 10 out of 1,000 treated people 
Rare: 1 to 10 out of 10,000 treated people 
Very rare: less than 1 out of 10,000 treated people, including singular incidents
The character of possible side effects also depends on the acupuncture points which were 
chosen for treatment. Please ask your doctor which points he or she will use. The following 
symptoms were experienced by patients treated with acupuncture:
Common: 1 to 10 out of 100 people treated 
Common side effects are bleeding and haematoma because of the lesion of small vessels. 
Sometimes, small bleedings are a desired part of Chinese acupuncture treatment.
Uncommon: 1 to 10 of 1,000 treated people 
Uncommon side effects observed in the context of acupuncture treatment include: inflamma-
tion at the application site, swelling, strong pain during needling, and local muscle pain. Nerve 
irritation or nerve injury is also possible. This can cause sensation difficulties or a temporary 
weakness in the associated musculature. Furthermore, headache, fatigue, and vegetative 
symptoms like vertigo and nausea were experienced. An initial aggravation of the symptoms 
which lead to the treatment is possible.
Rare: 1 to 10 out of 10,000 people treated 
Rare side effects include: local infection, redness, itching, sweating, decrease of blood  
pressure, increase in blood pressure, unconsciousness, tachycardia, breathing difficulties, 
vomiting, worsening health state, generalized muscle pain, restricted movement, joint prob-
lems, feeling of coldness, menstrual problems, depressive mood, anxiety, sleep disturbance, 
restlessness/ nervousness, disturbed vision and tinnitus.
Very rare: less than 1 out of 10,000 treated people, including singular incidents 
Side effects observed in the context of acupuncture treatment include: palpitations, consti-
pation, diarrhoea, gastrospasm, enterospasm, weight loss, circulatory disturbance, lesion 
of blood vessels, systemic infection, euphoria, nightmares, poor concentration, imbalance, 
disturbance of speech, disorientation, shivering, and eye irritation. Very rarely acupuncture 
needles can be forgotten or break. During treatment on the thorax a too deep insertion of an 
acupuncture needle can cause accumulation of air in the pleural cavity (pneumothorax). In 
the scientific literature injuries of the central nervous system and the pericardium have been 
reported. 
The application of heat through burning mugwort (moxibustion) can cause burns. 
Some of the side effects mentioned above can influence your fitness to drive!
If side effects occur during or after treatment, please inform your doctor.
Fig. 2. Risks of acupuncture treatment. 
recognise very rare complications, reflects acupuncture per-
formed by physicians in Germany, and helps minimise under-
reporting [35] and selection bias. Nonetheless, direct patient 
reports do have certain limitations – e.g. recall bias, overre-
porting, coincidence of acupuncture and undesirable effects, 
or vague causality – and there was no control group. Further-
more, only patients with chronic osteoarthritis pain of the 
knee or hip, low back pain, neck pain or headache, allergic 
rhinitis, asthma, or dysmenorrhoea were included in the study 
and auricular acupuncture or electro-stimulation were not 
performed. Nevertheless, these patients represent most of the 
patients treated with acupuncture in Germany. 
The type and frequency of adverse effects are difficult to 
compare between the various studies which evaluate acupunc-
ture adverse effects [12]. Studies can vary in many ways includ-
ing, among others, in the observed acupuncture technique, the 
number and type of patients included, the number of reported 
sessions, the training of the acupuncturist (MD vs. non-MD) 
and the conditions treated with acupuncture. Moreover, the 
methods used to define and document adverse effects differ. 
Both, physician and/or patient information are used to report 
adverse effects, after every session, after a treatment cycle, 
or, irrespective of the individual patient, all adverse effects in 
a certain time frame. Therefore, the incidence of adverse ef-
fects can be described per patient or per treatment session. 
However, we think two studies are comparable [28, 35] to our 
study, because they used either direct reports from patients 
of a large sample or included a comparably large sample of 
patients.
In 2002, MacPherson et al. [35] conducted a survey on the 
adverse events of acupuncture and also used direct reports 
of a large sample of patients. Of 9,408 recruited acupuncture 
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patients, 6,348 completed a questionnaire concerning adverse 
events after 3 months. The achieved sample reported an aver-
age of 4.8 acupuncture visits over the 3 months corresponding 
to a total of 30,196 consultations for the whole sample. 682 pa-
tients (10.7%) reported a total of 1,044 adverse events caused 
directly by the acupuncture treatment, with severe tiredness 
or exhaustion and prolonged or unacceptable pain at the site 
of needling as the most frequent adverse events. Less than 10 
visits, which was the average number of visits in our study, 
were reported. The percentage of patients reporting adverse 
effects was about 20% higher than the 8.6% (19,726) we 
found. In terms of the guidelines of the European Commis-
sion, used to describe adverse effects of medicinal products, 
MacPherson’s data would rate acupuncture adverse effects as 
‘very common’ whereas our results suggest them to be ‘com-
mon’. The frequency of specific adverse effects like fatigue or 
headache was different compared to our data. One possible 
explanation for the differences is that MacPherson et al. used 
checklists with tick boxes, which may have produced a higher 
reporting compared to the free text form we used. An inter-
esting question is whether the difference between our results 
and those of MacPherson can be explainded by the different 
type of provider. MacPherson et al. included non-physician 
acupuncturists whereas in our study, only physicians were 
included. Another study by MacPherson et al. [18], however, 
showed that the frequency of significant adverse events was 
comparable to that observed in a study by White et al. [36] 
which included doctors and physiotherapists (MacPherson: 1.3 
per 1,000 treatments vs. White: 14 per 10,000 consultations). 
The study by Melchart et al. [28] included 9,429 German 
physician acupuncturists of whom 7,050 reported adverse ef-
fects from 97,733 patients and approximately 760,000 sessions 
with an average of 7.8 acupuncture sessions per patient. They 
observed mild adverse effects in 7.1% of the patients, with nee-
dling pain and haematoma as the predominant effects. About 
15% less adverse effects than in our study were observed, pos-
sibly because of underreporting by physicians. Needling pain 
(3,202, 3.28%), however, was much more often reported than 
in our study (490, 0.21%). One possible explanation for this 
difference is the use of a tick box for needling pain.
Most of the very severe complications mentioned in the 
literature, e.g. cardiac tamponade or spinal cord injury [19, 
21, 37], were not reported in our study. On the other hand, 
pneumothorax was observed both in our study and in that 
of Melchart [28]. It is a possible complication which can be 
caused by the care provider, but also by the patients who can 
accidentally push a punctured needle deeper into the thorax 
with a blanket or towel used to keep them warm. Nerve le-
sions are also known significant complications [14, 15, 21, 38] 
which were also observed in our study, however, these were 
not permanent injuries. Skin infections are adverse effects [15, 
35] which might be avoidable. Tiredness or drowsiness, which 
was less observed in our study than it that by MacPherson et 
al. [35], is also a relevant adverse effect, because it affects the 
fitness to drive. In order to avoid unconsciousness or needle 
fainting, special care should be taken when inserting needles 
in a standing or sitting position or when a patient stands or 
sits up quickly after a treatment if the patient has little or no 
experience receiving acupuncture [19].
For the interpretation of events which we did not observe 
in our study but which are known from the literature, we can 
use a formula from Hanley and Lippman-Hand [39, 40]. Ac-
cording to this formula, a sample size needs to be 3 times n to 
have a 95% probability that no severe complication occurs in 
n treatments [18, 39, 40]. This shows that even with the high 
number of patients in our study, it is difficult to draw con-
clusions for extremely rare events. But we can state that the 
highest risk of experiencing an adverse effect which we did 
not observe in our study is about 1 in 76,000 patients, with 
95% probability. We think, very severe complications should 
not be overestimated but nonetheless, physicians and patients 
should be aware of them.
In out-patient care, the use of medical consent forms is es-
pecially difficult, because it is not an established practice; it is 
time consuming and seems impersonal. However, we want to 
motivate hospital and practice physicians to use an acupunc-
ture consent form to standardise patient information.
Balancing the patients’ needs for information and the legal 
aspects while avoiding information overload, was a difficult 
task in the process of developing the medical consent form. 
On the one hand the information should be clear and easy to 
understand for patients and doctors, but on the other hand, it 
should be detailed enough to fulfil all criteria in terms of con-
tent and legal aspects [25, 34]. Consequently, the present con-
sent form is a compromise. We decided to use the data from 
the ASH study as a basis. This data should represent the risk 
profile of most German patients treated with acupuncture in 
Germany and can help patients and physicians estimate the 
risk of adverse effects more accurately. 
It is interesting to note that similar conventional interven-
tions such as blood taking, injections or inserting peripheral 
intravenous lines are mostly performed without written in-
formed consent, i.e. only verbal consent is obtained. One ex-
planation might be that in most Western countries, acupunc-
ture is not yet part of conventional university medical educa-
tion or medical care, although it is becoming more and more 
common and increasingly integrated. Acupuncture is also used 
for the treatment of conditions although there is no clear sci-
entific evidence of its efficacy in this context. A comprehensi-
ble process of gaining informed consent could improve patient 
information and help avoid legal disputes. The presented data 
and the proposed consent form may help achieve this aim.
However, the process of gaining informed consent does 
take time which could otherwise be used for a more intense 
patient-doctor interaction. And the question has to be an-
swered what better helps to improve treatment safety: more 
bureaucracy or more time for intensive doctor-patient inter-
actions? In order to allow flexible use of the information and 
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consent form we propose a framework consisting of five mod-
ules which can be adapted according to condition and the in-
dividual patient. The modules or parts of them can also be in-
cluded in existing consent forms. Routine reporting of severe 
adverse effects could help to keep the data up-to-date.
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